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Abstract

Humanity has faced several foes over the centuries,
a formidable one amongst them is the current pandemic of COVID-19. The symptoms of COVID-19
are more or less related to the nose and throat. Therefore, patients more often present to Ear Nose Throat
(ENT) clinics with symptoms including cough, sore
throat, fever and shortness of breath. In the management of head and neck pathologies, as the airway is a
direct source of infection, the impact of COVID-19
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Humanity has faced several foes over the centuries,
a formidable one amongst them is the current pandemic of Corona virus disease of 2019 (COVID-19).
It is believed that it originated in Wuhan, the capital
city of Hubei province in the People’s Republic of
China, COVID-19 was labelled as a public health
emergency of international significance by World
Health Organization (WHO) in January 2020 (1).
The issue has raised hurdles in healthcare provision
in all medical sectors and has been dealt with in different ways. The pandemic is a stark reminder of the
emerging trends in infectious diseases and the need
for the constant evolution of healthcare.
In the management of head and neck pathologies,
as the airway is a direct source of infection, the
impact of COVID-19 holds special significance
(2). This review article has attempted to explain
the various aspects of the disease itself, providing
an overview of the evolving recommendations for
head and neck patients, the future outlook and the
limitations faced in developing countries, specifically for otorhinolaryngology patients.

holds special significance. This review has attempted
to explain the various aspects of the disease itself, its
diagnosis, the use of personal protective equipment
(PPE) to provide an overview of the evolving recommendations in head and neck patients, the future outlook and the limitations faced in developing countries
specifically for ENT patients.
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What Is COVID-19?
A brief history of Coronavirus
In the past two decades, there have been two catastrophic events where the Coronavirus crossing
over from animal to humans has resulted in severe disease. In 2002-2003, a new coronavirus of
β-genera originating from bats and crossing over
to humans via cats was designated as severe acute
respiratory syndrome coronavirus (SARS-CoV).
This virus affected 8,422 people, mostly in Guangdong province of China and some parts of Hong
Kong and caused more than 900 deaths with a
mortality rate of 11% (3). A decade later, another virus of bat origin emerged in Saudi Arabia in
2012 and was named as the Middle East respiratory syndrome coronavirus (MERS-CoV). Dromedary camels acted as the intermediate host and
up to 2,500 people were affected, out of whom 858
lost their lives with a fatality rate of 34% (4).
Viral etiology
According to the recent literature, SARS-CoV-2
resembles SARS-CoV and MERS-CoV. Being
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zoonotic, its probable origin is from horseshoe bats and pangolins acting as the most likely intermediate hosts (5, 6).
Epidemiological considerations
Mode of transmission: on the basis of epidemiological research and
the data available, it seems that the COVID-19 outbreak initially
began from an animal to the human transmission which then led
to human to human spread (7). It is now suggested that this interpersonal spread is due to contact transmission and via respiratory
droplets (8). Studies have found SARS-CoV-2 in the stool of few
patients with COVID-19 in China and the United States, and it
is considered that there may be a risk of fecal-oral transmission as
well (7). Although the spread of this virus through aerosols and
from mothers to newborn need yet to be confirmed (9, 10).
Source of transmission: The main sources of transmission of
the disease are those individuals who have tested positive for
COVID-19. Other than that, recent studies and observations
suggested that asymptomatic patients and those in their incubation period also act as carriers of SARS-CoV-2 and transmit the
disease. It is questionable whether or not patients in the recovery
phase are source of transmission (5, 11).
Incubation period: The estimated incubation period of COVID-19
is 5 to 6 days on the average. This can, however, go up to 14 days,
which, therefore, is adopted as the observation and quarantine
period for exposed persons (7). Few studies in the literature also
reported incubation periods up to 24 days (12).
Mortality rate: Current data suggests that mortality rate of
COVID-19 is 0.39% to 4.05% and comparatively lower than
those of SARS (mortality rate up to 10%) and MERS (mortality rate up to 34%). It is also higher than the mortality rate of
seasonal influenza, which accounts for up to 0.01% to 0.17% (7).
People at high risk: People of all ages are found to be susceptible
to this disease. Although people who have close contact with
patients infected with COVID-19, including healthcare professionals and other patients admitted in the hospital are at higher
risk (13). People with immunosuppression, multiple comorbidities and old age are considered to be at risk to become victims
of this infection.
Main Points

• The symptoms of COVID-19 are more or less related to the
nose and throat including cough, sore throat, fever, anosmia,
dysgeusia and shortness of breath.
• Hospitalized patients may require intensive care support and
can develop complications such as acute respiratory distress
syndrome, arrhythmia, shock, acute kidney injury, ultimately
leading to multi-organ failure and death.
• PPEs reduce risk of nosocomial infections, AAOHNS advocated adherence to respiratory droplet precautions by using eye
protection, gown, gloves and masks (N95 for procedures).
• Guidelines are being updated on almost daily basis, proper use
of PPE and a more stringent selection of patients for examination and surgical procedures the risk can be minimized.
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Clinical manifestations and complications
Infection is slightly more male predominant with a rate ranging
around 58% (14). The symptoms of COVID-19 are more or less
related to the nose and throat. Therefore, patients more often
present to Ear Nose Throat (ENT) clinics with symptoms including cough, sore throat, fever and shortness of breath. Other
atypical symptoms can include fatigue, headache, diarrhea, vomiting and confusion (13). Since some patients from China, Italy
and Iran have reported anosmia and dysgeusia, these should also
be considered when screening patients for COVID-19 (15).
One-fourth to one-third of hospitalized patients may require
intensive care support and can develop complications such as
acute respiratory distress syndrome, arrhythmia, shock, acute
kidney injury and acute liver disease, ultimately leading to the
vicious cycle of multi-organ failure and death (7).
Diagnosis and treatment
Laboratory workup may show raised C-reactive protein (CRP),
lactate dehydrogenase (LDH) and erythrocyte sedimentation
rate (ESR) levels along with lymphocytopenia (16). Since chest
X-ray and chest computed tomography (CT) show nonspecific
findings, the American College of Radiology (ACR) and the
Society of Thoracic Radiologists recommend that these techniques are not used for screening or for diagnostic purposes.
ACR recommended computed tomography (CT) should not be
used as first-line test to diagnose this condition but should be
reserved for hospitalized and symptomatic patients and appropriate infection control measures should be taken before scanning subsequent patients. Furthermore, ACR suggested that a
normal CT does not rule out COVID-19 infection and an abnormal CT is not specific for COVID-19 diagnosis (2).
Currently, the diagnosis of COVID-19 is made with polymerase
chain reaction (PCR) testing for nucleic acid sequence homology
in nasopharyngeal or throat swabs. The preferred site is the nasopharynx because of the higher viral load (17). The range of sensitivity of the PCR test reported in literature is from 30% to 60%.
This low sensitivity may be due to multiple external factors including inappropriate sampling technique or collection, transportation and quality or performance of the kits (18). Single negative
PCR test result from a suspected COVID-19 patient does not exclude the infection and may become positive on repeating the test,
and therefore we should be alert of the patients with COVID-19
related symptoms and suspected history (2). Serological testing
for COVID-19 is currently under development (19).
In a video, Marty et al. (20) demonstrated the proper technique
of obtaining specimens from the surface of the respiratory mucosa with nasopharyngeal swabs for the diagnosis of COVID-19
in adults and children.
Until now, there is no specific treatment available against this
infection, and therefore the current management of COVID-19
is to control the source of infection with the help of infection
control measures to decrease the risk of its transmission and
provision of early diagnosis, isolation and supportive care (7).
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Infection Control
Risk of nosocomial infection
The risk of nosocomial infection stems from multiple factors:
at the start of the pandemic, healthcare personnel did not have
adequate knowledge about the nature of the spread of the virus
and that led to incomplete protective measures, the increasing
workload led to fatigue, which in turn increased the probability
of acquiring the infection, and later in the course of the pandemic shortage of personal protective equipment (PPE) itself
became a grave concern (21).
Infection control guidelines and protocols
Various institutions introduced protocols to control infection
spread amongst healthcare workers (HCW). One Chinese hospital divided the strategy into branches like material allocation,
infection control training, a triage strategy, reducing hospital traffic, and a cleaner environment. They kept waiting-areas
apart, reduced appointments, relieved HCW >65 years of age
and attended only to emergencies. Surgical masks were made
compulsory on floors, and repeated temperature checks of patients were done. They restricted patient visitors to one and for
suspected patients they made an emergency isolation ward. Surgeries that were elective in nature were initially put on hold until control measures were established. These surgeries were then
started gradually to ensure familiarity with the new systems.
With these measures, they reported that they had no case of
nosocomial infection in their hospital (22).
More specific stringent measures were taken by the American Academy of Otolaryngology-Head and Neck Surgery
(AAOHNS) (23) that included cancellation of all elective cases,
converting all tracheotomies to percutaneous routes, keeping
patients intubated for up to three weeks, operating in negative
pressure operating room (OR), limiting the OR personnel with
teams involved in cases of suspected COVID patients. All endoscopic or skull base procedures were abandoned and all consults
for laryngoscopy, nasopharyngoscopy, nasal endoscopy, were
suspended unless needed in urgent/emergent situation. All clinic patients had their status rescheduled or offered telemedicine
visits.
Use of personal protective equipment (PPE)
PPEs reduce the risk of nosocomial infections, as seen during
the SARS outbreak (24). Thus, it was applied to mitigate the
COVID-19 spread. Previous studies proved masks a significant
source of contamination and otolaryngologists need to be adept
with proper procedures and cautions when removing or re-using masks (25). However, a recent systematic review meta-analyzed data from four randomized control trials (RCT) to conclude that “Low certainty evidence suggests that medical masks
and not resistant to oil (N95) respirators offer similar protection against viral respiratory infection including coronavirus in
healthcare workers during non-aerosol-generating care.” They
recommended N95 masks to be preserved for only aerosol-generating procedures (26).
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The AAOHNS produced guidelines for the proper use of PPE.
They advocated adherence to respiratory droplet precautions by
using eye protection, gown, gloves and masks (N95 for procedures), practice donning and removing PPE, confirm visibility,
maintain communication, assess fidelity to perform safe endoscopy and finally being alert to the possibility of asymptomatic
COVID-19 infection (23).
Recommendations for Otolaryngologists/Head and Neck
Surgeons
ENT/head and neck examination
Examination of patients presenting to otolaryngology clinic
with routine complaints is a challenge in the era of this pandemic. Public Health England (PHE) advised ENT physicians
to wear full PPE including N95 masks, gloves, gown and face
shield or goggles for all type of examinations or procedures in
all patients. They further suggested that for conditions not involving the oral cavity such as neck and skin lesions, routine
COVID PPE including gloves, surgical mask and apron could
be used (27).
Procedural considerations
Majority of the procedures in otolaryngology, especially oral,
nasal and airway surgeries put the surgeon at a higher risk of
contracting the disease. Here we briefly discuss the most important procedures.
Role of tracheotomies
A major complication of COVID 19 is acute respiratory distress
syndrome (ARDS) which requires mechanical ventilation, and
the timing and the need for tracheotomy in these patients is a
very pertinent question under the current conditions. In a small
sample of 28 patients, Mattioli et al. (28) reported no difference between percutaneous and surgical tracheotomy in terms
of timing and the number of affected team members; they also
suggested to do the tracheotomy on 7th to 14th days in selected patients. Guidelines issued by the Ear Nose Throat United
Kingdom (ENT UK) recommends COVID 19 testing in all
patients planned for tracheotomy. They further recommended
using cuffed non-fenestrated tracheotomy tubes, not piercing
the cuff of the endotracheal tube while performing tracheotomy
and ceasing ventilation while the window in the trachea is being
performed and prior to inserting the tracheostomy tube (29).
Full PPE including gown, gloves, N95 mask, face shield should
be used while performing the procedure.
Endoscopic sinus surgery
The viral load of COVID-19 is highest in the nasal cavity regardless of whether the patient is symptomatic or asymptomatic
(17). A case operated on in Wuhan, China for trans-nasal pituitary adenoma resulted in affecting more than 14 healthcare
workers who were involved in that surgery (30). Due to this
high potential for infectivity, we recommend that all cases of
non-emergent nature should be deferred indefinitely until more
data is available on this topic. In case of emergency, all necessary precautions should be observed. The number of people in
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the OR should be limited to only the necessary individuals, the
procedure should be performed by the consultant surgeon and
not by trainees to limit the time of exposure and all personnel
involved in the case should use proper PPEs including gowns,
gloves, N95 masks, face shields.
Ear surgery
Whether COVID-19 can involve the respiratory mucosa lining of the middle ear and the mastoid air cells is not known.
Since COVID-19 can involve the rest of the airway mucosa, it
is highly likely that it can also involve and infect the lining of the
eustachian tube, the middle ear and the mastoid cells.
Drilling the mastoid bone creates droplets and aerosols, and in the
presence of the virus, this procedure can cause all individuals in
operating room to be infected. Mastoidectomy is therefore considered a high-risk procedure. It is important to take all the necessary precautions and operate on only in emergency cases such
as those with complex chronic ear conditions. Ideally, preoperative
testing for COVID-19 should be performed in all patients undergoing ear surgery. Surgery should be deferred until the patient is
disease free in case patient’s test is positive for COVID-19 (31).
The Role of Head and Neck Surgeon During the COVID-19
Pandemic
Head and neck patients are known to practice self-referral (32).
Hence it is essential to run outpatient services at times when
the presentation of these patients to the emergency department
would lead to increased demand on an already over-burdened
department catering to patients of COVID-19.
Head and neck surgeons, together with anesthesiologists, are responsible for airway management. As more and more intensive
care staff are exposed to the disease, ENT doctors will be crucial
in the airway management of COVID-19 patients.
As the pandemic continues, there will be a rise in the number of
patients that require prolonged mechanical ventilation, hence an
increase in the number of tracheotomies performed. The mean
duration of viral shedding is 20 days (33). Tracheotomy produces aerosol and is a high-risk procedure in these patients (29).
ENT, as is the rest of medicine, will face a lot of challenges in the
few weeks to come. Let’s stay healthy, so we can help our patients.
Challenges Faced by Developing Countries
Many developing countries have been pushed into crisis after
the rapid spread of the novel coronavirus. Implementation of
countrywide lockdowns and standard operating procedures have
turned into great challenges in developing countries more than
in developed countries.
Health-related challenges
The expenditure of funds on healthcare systems in developing
countries is far less to enjoy better health services. Nearly all
healthcare systems worldwide are coping with problems of high
costs and lack of facilities.
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Developing countries have the lowest number of intensive care
units (ICU) per capita. The reason behind this is the cost of
trained healthcare workers, infrastructure, and supplies that are
required to establish a standard ICU (34).
People are devoid of the basic necessities that are essential for
prevention, including facemasks, gloves and disinfectants. With
the increasing number of cases, hospitals are facing a shortage of
testing kits and unable to perform mass screening (35).
Social challenges
A major amount of population in developing countries is living
in slums. In Mumbai, India, which is a city with a total surface
area of 603 kilometers squared, has an estimated population of
over 22 million that has doubled since 1991. The percentage of
people living in slums is estimated to be as high as 41.3% (36).
The population in such areas is so dense, and streets are not wide
enough to follow the social distancing guidelines. This makes
such areas a breeding ground for the virus. Many people do not
have access to clean drinking water, they have to travel daily to
fetch water from a local community water supply, where human
interaction is not a choice but a compulsion.
Economic challenges
Most of the people live hand-to-mouth on daily wages and cannot afford to stock up on food. So, they are faced with the dilemma of either going out to work and risk being contaminated or
staying at home and face extreme hunger. Once the lockdown is
implemented, taking care of such people becomes a responsibility of the state. And the states of developing countries in such
cases become handicapped.

Conclusion

COVID-19 has presented humanity with unprecedented challenges. Healthcare professionals are at considerably higher risk
due to the close contact with these patients. Otorhinolaryngologists are at greater risk as the viral load is greatest in the nasopharynx and oral cavity. The evidence is limited and guidelines
are being updated on almost daily basis. With proper use of
PPE and a more stringent selection of patients for examination
and surgical procedures the risk can be minimized.
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